{"pmid":32437767,"title":"COVID-19 in Dialysis Patients: Adding a Few More Pieces to the Puzzle.","text":["COVID-19 in Dialysis Patients: Adding a Few More Pieces to the Puzzle.","The clinical presentation and mortality rate in maintenance hemodialysis (MHD) patients with COVID-19 are not well established. Recent data from Italy and Spain suggest that these patients present with wide range of symptoms, with a significant portion being asymptomatic. There is prolonged positivity of pharyngeal swabs in MHD patients. The mortality rates are very high, reaching almost 30%. These data highlight the importance of diligent oversight and care of MHD patients during COVID-19 pandemic.","Kidney Int","Ikizler, T Alp","32437767"],"abstract":["The clinical presentation and mortality rate in maintenance hemodialysis (MHD) patients with COVID-19 are not well established. Recent data from Italy and Spain suggest that these patients present with wide range of symptoms, with a significant portion being asymptomatic. There is prolonged positivity of pharyngeal swabs in MHD patients. The mortality rates are very high, reaching almost 30%. These data highlight the importance of diligent oversight and care of MHD patients during COVID-19 pandemic."],"journal":"Kidney Int","authors":["Ikizler, T Alp"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437767","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.kint.2020.04.032","locations":["Italy","Spain"],"countries":["Italy","Spain"],"countries_codes":["ITA|Italy","ESP|Spain"],"weight":0,"_version_":1667521393639555073,"score":9.490897,"similar":[{"pmid":32437770,"title":"COVID-19: Clinical course and outcomes of 36 maintenance hemodialysis patients from a single center in Spain.","text":["COVID-19: Clinical course and outcomes of 36 maintenance hemodialysis patients from a single center in Spain.","SARS-CoV-2-pneumonia emerged in Wuhan, China in December 2019. Unfortunately, there is lack of evidence about the optimal management of novel coronavirus disease 2019 (COVID-19), even less in patients on maintenance hemodialysis (MHD) therapy than in the general population. In this retrospective observational single-center study we analyzed the clinical course and outcomes of all MHD patients hospitalized with COVID-19 from March 12(th) to April 10(th), 2020 as confirmed by real time polymerase chain reaction. Baseline features, clinical course, laboratory data, and different therapies were compared between survivors and non-survivors to identify risk factors associated with mortality. Among the 36 patients, 11 (30.5%) died and 7 could be discharged within the observation period. Clinical and radiological evolution during the first week of admission were predictive of mortality. Among the 36 patients, 18 had worsening of their clinical status, as defined by severe hypoxia with oxygen therapy requirements greater than 4 Liters/minute and radiological worsening. Significantly 11 out of those 18 patients (61.1%) died. None of the classical cardiovascular risk factors in the general population were associated with higher mortality. However, a longer time on hemodialysis (hazard ratio 1.008(95% confidence interval 1.001-1.015) per year), increased LDH levels (1.006(1.001-1.011), and lower lymphocyte count (0.996 (0.992-1.000) one week after clinical onset were all significantly associated with higher mortality risk. Thus, the mortality among hospitalized hemodialysis patients diagnosed with COVID-19 is high. Lymphopenia and increased LDH levels were associated with poor prognosis.","Kidney Int","Goicoechea, Marian","Sanchez Camara, Luis Alberto","Macias, Nicolas","Munoz de Morales, Alejandra","Gonzalez Rojas, Angela","Bascunana, Arturo","Arroyo, David","Vega, Almudena","Abad, Soraya","Verde, Eduardo","Garcia Prieto, Ana Maria","Verdalles, Ursula","Barbieri, Diego","Felipe Delgado, Andres","Carbayo, Javier","Mijaylova, Antonia","Perez de Jose, Ana","Melero, Rosa","Tejedor, Alberto","Rodriguez Benitez, Patrocinio","de Jose, Ana Perez","Rodriguez Ferrero, Maria Luisa","Anaya, Fernando","Rengel, Manuel","Barraca, Daniel","Luno, Jose","Aragoncillo, Ines","32437770"],"abstract":["SARS-CoV-2-pneumonia emerged in Wuhan, China in December 2019. Unfortunately, there is lack of evidence about the optimal management of novel coronavirus disease 2019 (COVID-19), even less in patients on maintenance hemodialysis (MHD) therapy than in the general population. In this retrospective observational single-center study we analyzed the clinical course and outcomes of all MHD patients hospitalized with COVID-19 from March 12(th) to April 10(th), 2020 as confirmed by real time polymerase chain reaction. Baseline features, clinical course, laboratory data, and different therapies were compared between survivors and non-survivors to identify risk factors associated with mortality. Among the 36 patients, 11 (30.5%) died and 7 could be discharged within the observation period. Clinical and radiological evolution during the first week of admission were predictive of mortality. Among the 36 patients, 18 had worsening of their clinical status, as defined by severe hypoxia with oxygen therapy requirements greater than 4 Liters/minute and radiological worsening. Significantly 11 out of those 18 patients (61.1%) died. None of the classical cardiovascular risk factors in the general population were associated with higher mortality. However, a longer time on hemodialysis (hazard ratio 1.008(95% confidence interval 1.001-1.015) per year), increased LDH levels (1.006(1.001-1.011), and lower lymphocyte count (0.996 (0.992-1.000) one week after clinical onset were all significantly associated with higher mortality risk. Thus, the mortality among hospitalized hemodialysis patients diagnosed with COVID-19 is high. Lymphopenia and increased LDH levels were associated with poor prognosis."],"journal":"Kidney Int","authors":["Goicoechea, Marian","Sanchez Camara, Luis Alberto","Macias, Nicolas","Munoz de Morales, Alejandra","Gonzalez Rojas, Angela","Bascunana, Arturo","Arroyo, David","Vega, Almudena","Abad, Soraya","Verde, Eduardo","Garcia Prieto, Ana Maria","Verdalles, Ursula","Barbieri, Diego","Felipe Delgado, Andres","Carbayo, Javier","Mijaylova, Antonia","Perez de Jose, Ana","Melero, Rosa","Tejedor, Alberto","Rodriguez Benitez, Patrocinio","de Jose, Ana Perez","Rodriguez Ferrero, Maria Luisa","Anaya, Fernando","Rengel, Manuel","Barraca, Daniel","Luno, Jose","Aragoncillo, Ines"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437770","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.kint.2020.04.031","keywords":["coronavirus","covid-19","hemodialysis","sars-cov-2","mortality"],"locations":["Wuhan","China","optimal","Lymphopenia","Spain"],"countries":["China","Spain"],"countries_codes":["CHN|China","ESP|Spain"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667521393724489728,"score":181.95456},{"pmid":32340018,"title":"Coronavirus Disease 2019 in a Hemodialysis Patient.","text":["Coronavirus Disease 2019 in a Hemodialysis Patient.","There has been a global outbreak of the coronavirus disease 2019 (COVID-19) since December 2019. Here, we describe the case of a 49-year-old male undergoing maintenance hemodialysis (HD) who got infected with COVID-19 and our experience in performing HD for him. The patient's symptoms and lung imaging changes were atypical. However, his lymphocyte range decreased upon admission and the polymerase chain reaction of the pharyngeal swab for the -COVID-19 nucleic acid was positive. The patient developed respiratory failure and required mechanical ventilation 8 days after admission. In the end, he died from multiple organ dysfunction syndrome. The difficulties in diagnosis, infection control, and treatment of COVID-19 in maintenance HD patients are discussed in this report.","Blood Purif","Yuan, Hai","Guo, E","Gao, Zhao","Hu, Fengqi","Lu, Li","32340018"],"abstract":["There has been a global outbreak of the coronavirus disease 2019 (COVID-19) since December 2019. Here, we describe the case of a 49-year-old male undergoing maintenance hemodialysis (HD) who got infected with COVID-19 and our experience in performing HD for him. The patient's symptoms and lung imaging changes were atypical. However, his lymphocyte range decreased upon admission and the polymerase chain reaction of the pharyngeal swab for the -COVID-19 nucleic acid was positive. The patient developed respiratory failure and required mechanical ventilation 8 days after admission. In the end, he died from multiple organ dysfunction syndrome. The difficulties in diagnosis, infection control, and treatment of COVID-19 in maintenance HD patients are discussed in this report."],"journal":"Blood Purif","authors":["Yuan, Hai","Guo, E","Gao, Zhao","Hu, Fengqi","Lu, Li"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32340018","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1159/000507877","keywords":["coronavirus disease 19","end-stage renal disease","hemodialysis","severe acute respiratory syndrome-cov-2"],"topics":["Case Report"],"weight":1,"_version_":1666138494155620353,"score":83.80936},{"pmid":32385130,"title":"Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.","text":["Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.","BACKGROUND: Reports indicate that those most vulnerable to developing severe coronavirus disease 2019 (COVID-19) are older adults and those with underlying illnesses, such as diabetes mellitus, hypertension, or cardiovascular disease, which are common comorbidities among patients undergoing maintenance hemodialysis. However, there is limited information about the clinical characteristics of hemodialysis patients with COVID-19 or about interventions to control COVID-19 in hemodialysis centers. METHODS: We collected data retrospectively through an online registration system that includes all patients receiving maintenance hemodialysis at 65 centers in Wuhan, China. We reviewed epidemiologic and clinical data of patients with laboratory-confirmed COVID-19 between January 1, 2020 and March 10, 2020. RESULTS: Of 7154 patients undergoing hemodialysis, 154 had laboratory-confirmed COVID-19. The mean age of the 131 patients in our analysis was 63.2 years; 57.3% were men. Many had underlying comorbidities, with cardiovascular disease (including hypertension) being the most common (68.7%). Only 51.9% of patients manifested fever; 21.4% of infected patients were asymptomatic. The most common finding on chest computed tomography (CT) was ground-grass or patchy opacity (82.1%). After initiating comprehensive interventions-including entrance screening of body temperature and symptoms, universal chest CT and blood tests, and other measures-new patients presenting with COVID-19 peaked at 10 per day on January 30, decreasing to 4 per day on February 11. No new cases occurred between February 26 and March 10, 2020. CONCLUSIONS: We found that patients receiving maintenance hemodialysis were susceptible to COVID-19 and that hemodialysis centers were high-risk settings during the epidemic. Increasing prevention efforts, instituting universal screening, and isolating patients with COVID-19 and directing them to designated hemodialysis centers were effective in preventing the spread of COVID-19 in hemodialysis centers.","J Am Soc Nephrol","Xiong, Fei","Tang, Hui","Liu, Li","Tu, Can","Tian, Jian-Bo","Lei, Chun-Tao","Liu, Jing","Dong, Jun-Wu","Chen, Wen-Li","Wang, Xiao-Hui","Luo, Dan","Shi, Ming","Miao, Xiao-Ping","Zhang, Chun","32385130"],"abstract":["BACKGROUND: Reports indicate that those most vulnerable to developing severe coronavirus disease 2019 (COVID-19) are older adults and those with underlying illnesses, such as diabetes mellitus, hypertension, or cardiovascular disease, which are common comorbidities among patients undergoing maintenance hemodialysis. However, there is limited information about the clinical characteristics of hemodialysis patients with COVID-19 or about interventions to control COVID-19 in hemodialysis centers. METHODS: We collected data retrospectively through an online registration system that includes all patients receiving maintenance hemodialysis at 65 centers in Wuhan, China. We reviewed epidemiologic and clinical data of patients with laboratory-confirmed COVID-19 between January 1, 2020 and March 10, 2020. RESULTS: Of 7154 patients undergoing hemodialysis, 154 had laboratory-confirmed COVID-19. The mean age of the 131 patients in our analysis was 63.2 years; 57.3% were men. Many had underlying comorbidities, with cardiovascular disease (including hypertension) being the most common (68.7%). Only 51.9% of patients manifested fever; 21.4% of infected patients were asymptomatic. The most common finding on chest computed tomography (CT) was ground-grass or patchy opacity (82.1%). After initiating comprehensive interventions-including entrance screening of body temperature and symptoms, universal chest CT and blood tests, and other measures-new patients presenting with COVID-19 peaked at 10 per day on January 30, decreasing to 4 per day on February 11. No new cases occurred between February 26 and March 10, 2020. CONCLUSIONS: We found that patients receiving maintenance hemodialysis were susceptible to COVID-19 and that hemodialysis centers were high-risk settings during the epidemic. Increasing prevention efforts, instituting universal screening, and isolating patients with COVID-19 and directing them to designated hemodialysis centers were effective in preventing the spread of COVID-19 in hemodialysis centers."],"journal":"J Am Soc Nephrol","authors":["Xiong, Fei","Tang, Hui","Liu, Li","Tu, Can","Tian, Jian-Bo","Lei, Chun-Tao","Liu, Jing","Dong, Jun-Wu","Chen, Wen-Li","Wang, Xiao-Hui","Luo, Dan","Shi, Ming","Miao, Xiao-Ping","Zhang, Chun"],"date":"2020-05-10T11:00:00Z","year":2020,"_id":"32385130","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1681/ASN.2020030354","keywords":["covid-19","clinical characteristics","interventions","hemodialysis"],"locations":["Wuhan","China","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Diagnosis"],"weight":1,"_version_":1666340101995626497,"score":79.9365},{"pmid":32425224,"pmcid":"PMC7231728","title":"[SOLVING ONE OF THE PIECES OF THE PUZZLE: COVID-19 AND TYPE 2 DIABETES].","text":["[SOLVING ONE OF THE PIECES OF THE PUZZLE: COVID-19 AND TYPE 2 DIABETES].","The emergence of the COVID-19 pandemic represents an enormous challenge. Given the considerable presence of type 2 diabetes mellitus in the current population, the pandemic is a health issue that requires an effort to provide better responses to our patients who are more vulnerable to the onset of infection and who are candidates for presenting more severe symptoms. This document attempts to address the relationship between COVID-19 infection and type 2 diabetes mellitus. To this end, we will briefly analyse whether the epidemiological data support this association and, subsequently, go in depth on the pathophysiological mechanisms that might connect the two diseases.","Rev Clin Esp","Perez-Martinez, P","Carrasco Sanchez, F J","Carretero Gomez, J","Gomez-Huelgas, R","32425224"],"abstract":["The emergence of the COVID-19 pandemic represents an enormous challenge. Given the considerable presence of type 2 diabetes mellitus in the current population, the pandemic is a health issue that requires an effort to provide better responses to our patients who are more vulnerable to the onset of infection and who are candidates for presenting more severe symptoms. This document attempts to address the relationship between COVID-19 infection and type 2 diabetes mellitus. To this end, we will briefly analyse whether the epidemiological data support this association and, subsequently, go in depth on the pathophysiological mechanisms that might connect the two diseases."],"journal":"Rev Clin Esp","authors":["Perez-Martinez, P","Carrasco Sanchez, F J","Carretero Gomez, J","Gomez-Huelgas, R"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425224","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.rce.2020.05.003","keywords":["angiotensin-converting enzyme 2","covid-19","dipeptidyl peptidase-4 enzyme","glucagon-like peptide analogues","sodium-glucose cotransporter 2 inhibitors","type 2 diabetes mellitus"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667352728877137921,"score":77.56836},{"pmid":32444393,"title":"Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.","text":["Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.","BACKGROUND AND OBJECTIVES: Previous reports on the outbreak of coronavirus disease 2019 were on the basis of data from the general population. Our study aimed to investigate the clinical features of patients on maintenance hemodialysis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this retrospective, single-center study, we included 49 hospitalized patients on maintenance hemodialysis and 52 hospitalized patients without kidney failure (controls) with confirmed coronavirus disease 2019 at Tongren Hospital of Wuhan University from January 30, 2020 to March 10, 2020. Demographic, clinical, laboratory, and radiologic characteristics and treatment and outcomes data were analyzed. The final date of follow-up was March 19, 2020. RESULTS: The median age of 101 patients was 62 years (interquartile range, 49-72). All patients were local residents of Wuhan. In terms of common symptoms, there were differences between patients on hemodialysis and controls (fatigue [59% versus 83%], dry cough [49% versus 71%], and fever [47% versus 90%]). Lymphocyte counts were decreased (0.8x10(9)/L [patients on hemodialysis] versus 0.9x10(9)/L [controls], P=0.02). Comparing patients on hemodialysis with controls, creatine kinase-muscle and brain type, myoglobin, hypersensitive troponin I, B-type natriuretic peptide, and procalcitonin were increased, and the percentage of abnormalities in bilateral lung was higher in computed tomographic scan (82% versus 69%, P=0.15) and unilateral lung was lower (10% versus 27%, P=0.03). Common complications including shock, acute respiratory distress syndrome, arrhythmia, and acute cardiac injury in patients on hemodialysis were significantly higher. Compared with controls, more patients on hemodialysis received noninvasive ventilation (25% versus 6%, P=0.008). As of March 19, 2020, three patients on hemodialysis (6%) were transferred to the intensive care unit and received invasive ventilation. Seven patients on hemodialysis (14%) had died. CONCLUSIONS: The main symptoms of coronavirus disease 2019 pneumonia, including fever and cough, were less common in patients on hemodialysis. Patients on hemodialysis with coronavirus disease 2019 were at higher risk of death.","Clin J Am Soc Nephrol","Wu, Jun","Li, Jushuang","Zhu, Geli","Zhang, Yanxia","Bi, Zhimin","Yu, Yean","Huang, Bo","Fu, Shouzhi","Tan, Yiqing","Sun, Jianbin","Li, Xiangyou","32444393"],"abstract":["BACKGROUND AND OBJECTIVES: Previous reports on the outbreak of coronavirus disease 2019 were on the basis of data from the general population. Our study aimed to investigate the clinical features of patients on maintenance hemodialysis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this retrospective, single-center study, we included 49 hospitalized patients on maintenance hemodialysis and 52 hospitalized patients without kidney failure (controls) with confirmed coronavirus disease 2019 at Tongren Hospital of Wuhan University from January 30, 2020 to March 10, 2020. Demographic, clinical, laboratory, and radiologic characteristics and treatment and outcomes data were analyzed. The final date of follow-up was March 19, 2020. RESULTS: The median age of 101 patients was 62 years (interquartile range, 49-72). All patients were local residents of Wuhan. In terms of common symptoms, there were differences between patients on hemodialysis and controls (fatigue [59% versus 83%], dry cough [49% versus 71%], and fever [47% versus 90%]). Lymphocyte counts were decreased (0.8x10(9)/L [patients on hemodialysis] versus 0.9x10(9)/L [controls], P=0.02). Comparing patients on hemodialysis with controls, creatine kinase-muscle and brain type, myoglobin, hypersensitive troponin I, B-type natriuretic peptide, and procalcitonin were increased, and the percentage of abnormalities in bilateral lung was higher in computed tomographic scan (82% versus 69%, P=0.15) and unilateral lung was lower (10% versus 27%, P=0.03). Common complications including shock, acute respiratory distress syndrome, arrhythmia, and acute cardiac injury in patients on hemodialysis were significantly higher. Compared with controls, more patients on hemodialysis received noninvasive ventilation (25% versus 6%, P=0.008). As of March 19, 2020, three patients on hemodialysis (6%) were transferred to the intensive care unit and received invasive ventilation. Seven patients on hemodialysis (14%) had died. CONCLUSIONS: The main symptoms of coronavirus disease 2019 pneumonia, including fever and cough, were less common in patients on hemodialysis. Patients on hemodialysis with coronavirus disease 2019 were at higher risk of death."],"journal":"Clin J Am Soc Nephrol","authors":["Wu, Jun","Li, Jushuang","Zhu, Geli","Zhang, Yanxia","Bi, Zhimin","Yu, Yean","Huang, Bo","Fu, Shouzhi","Tan, Yiqing","Sun, Jianbin","Li, Xiangyou"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32444393","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.2215/CJN.04160320","keywords":["coronavirus","kidney failure; maintenance hemodialysis","severe acute respiratory syndrome coronavirus 2; covid-19"],"locations":["Wuhan","Pneumonia","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1667600475928657920,"score":70.21745}]}